Tyra Biosciences, Inc.TYRA stock score: 31/100

$19.73 · +0.61% · Scored Nov 19, 2026

Technical
38
Fundamental
30
News
54

The reading

Tyra Biosciences (TYRA) scores 31 out of 100, which reads bearish, higher than 5% of Healthcare stocks and 7% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 30, technicals 38.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Return on Equity (ROE) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 24 and contrarian oscillators 65 — a split worth reading before trusting the technical total.

News sentiment is neutral at 54; it is shown, not counted in the composite.

Since Aug 22, 2026 the composite has ranged from 31 to 47, and it is down 11 points over the period.

About Tyra Biosciences

Tyra Biosciences (TYRA) is a clinical-stage biotechnology company based in Carlsbad, California, that develops precision drugs aimed at fibroblast growth factor receptors, a family of proteins that drive some cancers and genetic growth disorders. Its lead candidate, dabogratinib, is an oral drug designed to block FGFR3 selectively while sparing related receptors, which may limit the side effects seen with broader FGFR inhibitors. The company is developing dabogratinib in three areas: intermediate-risk non-muscle invasive bladder cancer, low-grade upper tract urothelial cancer and achondroplasia, the most common form of dwarfism, where it has received orphan drug and rare pediatric disease designations. It has stepped back from metastatic bladder cancer to focus on these indications. Tyra has no product revenue and funds research with cash raised from investors.

In achondroplasia, Tyra competes with BioMarin, which sells Voxzogo, as well as BridgeBio and Ascendis Pharma, which are developing other treatments. In bladder cancer it competes with Johnson & Johnson’s FGFR-targeted products and with other therapies for early-stage disease. Its edge rests on an oral, FGFR3-selective drug that could be given as a pill in both cancer and a pediatric bone disorder, along with in-house structure-based drug design. Investors who follow TYRA stock tend to watch clinical data from its bladder cancer and achondroplasia trials. Dose escalation progress and safety findings are closely followed. Cash runway and plans for late-stage studies are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward TYRA’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

30

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

26 weighted scorers; 13 had no data today and are left out rather than counted as zero.

Technical · daily

29

Pulling it up

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Stochastic RSI combines Stochastic and RSI indicators for enhanced sensitivity to overbought/oversold conditions.

  • Williams %R (14-period) measures where the current price sits within the recent high-low range.

Holding it back

  • Simple Moving Average (200-period) is the most widely followed long-term trend indicator.

  • Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • Simple Moving Average (100-period) provides a longer-term perspective on price trends.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
54

Technical score by timeframe

ChartScoreWeight
Hourly541
Daily293
Weekly342
Monthly482

Composite score, last 90 days

05010031Aug 22, 2026Nov 19, 2026Aug 22, 2026: 42Aug 23, 2026: 42Aug 24, 2026: 42Aug 25, 2026: 44Aug 26, 2026: 46Aug 27, 2026: 43Aug 28, 2026: 40Aug 29, 2026: 40Aug 30, 2026: 41Aug 31, 2026: 40Sep 1, 2026: 43Sep 2, 2026: 44Sep 3, 2026: 42Sep 4, 2026: 47Sep 5, 2026: 47Sep 6, 2026: 46Sep 7, 2026: 46Sep 8, 2026: 46Sep 9, 2026: 39Sep 10, 2026: 41Sep 11, 2026: 40Sep 12, 2026: 40Sep 13, 2026: 40Sep 14, 2026: 43Sep 15, 2026: 44Sep 16, 2026: 40Sep 17, 2026: 42Sep 18, 2026: 44Sep 19, 2026: 44Sep 20, 2026: 44Sep 21, 2026: 44Sep 22, 2026: 43Sep 23, 2026: 42Sep 24, 2026: 41Sep 25, 2026: 39Sep 26, 2026: 40Sep 27, 2026: 40Sep 28, 2026: 39Sep 29, 2026: 41Sep 30, 2026: 40Oct 1, 2026: 39Oct 2, 2026: 38Oct 3, 2026: 39Oct 4, 2026: 39Oct 5, 2026: 39Oct 6, 2026: 39Oct 7, 2026: 39Oct 8, 2026: 39Oct 9, 2026: 39Oct 10, 2026: 37Oct 11, 2026: 38Oct 12, 2026: 38Oct 13, 2026: 36Oct 14, 2026: 36Oct 15, 2026: 36Oct 16, 2026: 36Oct 17, 2026: 36Oct 18, 2026: 36Oct 19, 2026: 38Oct 20, 2026: 40Oct 21, 2026: 40Oct 22, 2026: 42Oct 23, 2026: 41Oct 24, 2026: 41Oct 25, 2026: 40Oct 26, 2026: 41Oct 27, 2026: 42Oct 28, 2026: 41Oct 29, 2026: 42Oct 30, 2026: 41Nov 1, 2026: 41Nov 2, 2026: 43Nov 3, 2026: 43Nov 4, 2026: 42Nov 5, 2026: 40Nov 6, 2026: 40Nov 7, 2026: 41Nov 8, 2026: 41Nov 10, 2026: 42Nov 11, 2026: 40Nov 12, 2026: 31Nov 13, 2026: 32Nov 14, 2026: 32Nov 15, 2026: 32Nov 16, 2026: 31Nov 17, 2026: 31Nov 18, 2026: 31Nov 19, 2026: 31
Show the daily numbers
DateComposite
Nov 19, 202631
Nov 18, 202631
Nov 17, 202631
Nov 16, 202631
Nov 15, 202632
Nov 14, 202632
Nov 13, 202632
Nov 12, 202631
Nov 11, 202640
Nov 10, 202642
Nov 8, 202641
Nov 7, 202641
Nov 6, 202640
Nov 5, 202640
Nov 4, 202642
Nov 3, 202643
Nov 2, 202643
Nov 1, 202641
Oct 30, 202641
Oct 29, 202642
Oct 28, 202641
Oct 27, 202642
Oct 26, 202641
Oct 25, 202640
Oct 24, 202641
Oct 23, 202641
Oct 22, 202642
Oct 21, 202640
Oct 20, 202640
Oct 19, 202638
Oct 18, 202636
Oct 17, 202636
Oct 16, 202636
Oct 15, 202636
Oct 14, 202636
Oct 13, 202636
Oct 12, 202638
Oct 11, 202638
Oct 10, 202637
Oct 9, 202639
Oct 8, 202639
Oct 7, 202639
Oct 6, 202639
Oct 5, 202639
Oct 4, 202639
Oct 3, 202639
Oct 2, 202638
Oct 1, 202639
Sep 30, 202640
Sep 29, 202641
Sep 28, 202639
Sep 27, 202640
Sep 26, 202640
Sep 25, 202639
Sep 24, 202641
Sep 23, 202642
Sep 22, 202643
Sep 21, 202644
Sep 20, 202644
Sep 19, 202644
Sep 18, 202644
Sep 17, 202642
Sep 16, 202640
Sep 15, 202644
Sep 14, 202643
Sep 13, 202640
Sep 12, 202640
Sep 11, 202640
Sep 10, 202641
Sep 9, 202639
Sep 8, 202646
Sep 7, 202646
Sep 6, 202646
Sep 5, 202647
Sep 4, 202647
Sep 3, 202642
Sep 2, 202644
Sep 1, 202643
Aug 31, 202640
Aug 30, 202641
Aug 29, 202640
Aug 28, 202640
Aug 27, 202643
Aug 26, 202646
Aug 25, 202644
Aug 24, 202642
Aug 23, 202642
Aug 22, 202642

Key facts

Market cap
$1.4B
Sector
Healthcare
Industry
Biotechnology
Beta
0.67
Risk grade (1–10)
8
Next earnings
Nov 10, 2026

Questions

What is TYRA's stock rating today?

TYRA scores 31/100 (Bearish) as of Nov 19, 2026: technical 38, fundamental 30, and news sentiment 54, which is shown but not counted. Scores are recomputed every night.

What does Tyra Biosciences do?

Tyra Biosciences (TYRA) is a clinical-stage biotechnology company based in Carlsbad, California, that develops precision drugs aimed at fibroblast growth factor receptors, a family of proteins that drive some cancers and genetic growth disorders. Its lead candidate, dabogratinib, is an oral drug designed to block FGFR3 selectively while sparing related receptors, which may limit the side effects seen with broader FGFR inhibitors.

Is TYRA stock a buy?

The score is not a buy or sell recommendation. A 31 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the TYRA score calculated?

88 weighted scorers feed it today: 26 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

TYRA stock score

HTML

<a href="https://stocksscores.com/stocks/tyra/"><img src="https://stocksscores.com/stocks/tyra/badge.svg" alt="TYRA stock score" height="20"></a>

Markdown

[![TYRA stock score](https://stocksscores.com/stocks/tyra/badge.svg)](https://stocksscores.com/stocks/tyra/)